Concepedia

Author

Tiberio Oggionni

Istituti di Ricovero e Cura a Carattere ScientificoORCID

Also Known As

Federica Meloni, Giulio Mensi, Michele Sachs, Oggionni Tiberio, Oggionni, Tiberio, T Oggionni, T. Oggionni, Tiberio Oggionni

100

Publications

2.1K

Citations

28

H-Index

73

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere ScientificoUniversity of PaviaPoliclinico San Matteo FondazioneUniversity of MilanMultiMedica
TO

About

Tiberio Oggionni is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, immunology, and pulmonary disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

16

687

2

Cell Biology

3

3

95

3

Allergy

2

2

67

4

Public Health

1

1

130

5

Biochemistry

1

1

50

Tiberio Oggionni

×

35

Publications

1.8K

Citations

26

H-Index

YearCitations

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection

Natalia Sherina, Antonio Piralla, Likun Du,

Med

2021

196

Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia

Francesco Salton, Paola Confalonieri, G. Umberto Meduri,

Open Forum Infectious Diseases

2020

143

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial

Patrizio Vitulo, Anna Agnese Stanziola, Marco Confalonieri,

The Journal of Heart and Lung Transplantation

2016

130

Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome

Federica Meloni, Patrizio Vitulo, A BIANCO,

Transplantation

2004

128

Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients

Giuseppe Gerna, Patrizio Vitulo, Francesca Rovida,

Journal of Medical Virology

2006

106

One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study

Paola Faverio, Fabrizio Luppi, Paola Rebora,

Respiratory Research

2022

87

Immunity to SARS-CoV-2 up to 15 months after infection

Harold Marcotte, Antonio Piralla, Fanglei Zuo,

iScience

2022

78

Evaluation of Cytomegalovirus DNAaemia versus pp65-Antigenaemia Cutoff for Guiding Preemptive therapy in Transplant Recipients: A Randomized Study

Giuseppe Gerna, Fausto Baldanti, Maria Torsellini,

Antiviral Therapy

2007

65

Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis

Claudia Del Fante, Luigia Scudeller, Tiberio Oggionni,

Respiration

2015

57

Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection

Natalia Sherina, Antonio Piralla, Likun Du,

2020

55

Page 1